The Transformational Role of Digital Health and RWE Addressed at ISPOR Conference

Nearly 4,000 healthcare stakeholders from 70 countries convened in Baltimore, MD to discuss the latest trends shaping today’s global healthcare system. The conference theme, “Real-World Evidence, Digital Health, and the New Landscape for Health Decision Making,” sparked discussion and debate among policymakers, global thought leaders, researchers and academicians, public and private payers, decision makers, and patient representatives.

In addition to the plenaries and spotlight sessions focused on the conference theme, ISPOR 2018 explored other compelling topics in healthcare, including sessions on patient experience data, value assessment, artificial intelligence, and drug spending in the United States. Describing ISPOR’s role in facilitating an international dialogue on these issues, ISPOR’s Chief Executive Officer and Executive Director Nancy S. Berg noted, “This year’s focus on digital health, real-world evidence, and the changing healthcare landscape could not be more timely. It is gratifying to see that ISPOR is leading at a time when solid approaches to decision making are more important than ever.”

ISPOR, the professional society for health economics and outcomes research, is recognized globally for its scientific conferences, state-of-the-art educational programs, and high-impact journals. For more information, visit

Spotlight Session speaker Harlan M. Krumholz, MD, SM (Yale).
ISPOR’s Chief Science Officer Richard J. Willke, PhD.
ISPOR President-Elect Federico Augustovski, MD, MSc, PhD.
ISPOR 2018 Conference Program Chairs (from left to right: C. Daniel Mullins, PhD, Program Chair; Shelby D. Reed, PhD, RPh, ISPOR President; and Rachael L. Fleurence, PhD.
Members of ISPOR staff readying for the conference.


You May Also Like

It Depends on Where You Stand

In the film Beaches, CC Bloom, Bette Midler’s character, delivers the memorable line: “But ...

PM360 Presents Healthcare Heroes

We know millions of healthcare workers across the U.S. are doing courageous work during ...

The Changing Landscape of the MS Market

MS patients typically stick with their initial treatment—they are even more willing to discontinue ...